Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032

Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032

The global superdisintegrants market size is expected to reach USD 829.54 million by 2032, according to a new study by Polaris Market Research. The report “Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has increased the demand for drugs. Superdisintegrants play a vital role in formulating these drugs, making them essential components in the pharmaceutical industry. The most non-communicable disease deaths (NCD), 17.9 million per year, are caused by cardiovascular diseases, followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (1.2 million) (2.0 million, including fatalities from renal disease brought on by diabetes)). This will drive the growth of the market in the upcoming years.

Advancements in technology have led to the development of new and more efficient super disintegrants. For instance, recent studies have investigated using banana powder as a super disintegrant in various pharmaceutical formulations, including tablets and capsules. This has led to increased use of these excipients in formulating multiple drugs. The demand for generic drugs is rising due to their affordability and accessibility.

The increasing use of super disintegrants in the pharmaceutical industry, coupled with the growing number of patents being filed for new and innovative solutions, is driving the growth of the super disintegrants market. According to the combination of data from the National Institute of Standards & Technology (NIST) and the United Nations Patent and Trademark Office (USPTO), N-Vinyl pyrrolidone+sodium starch glycolate has 15 patents, followed by Amylose with 14 patents. This trend is expected to continue in the coming years as drug manufacturers seek to develop more efficient and effective drug delivery systems.

Superdisintegrants Market Report Highlights

Crospovidone segment is anticipated to grow due to increasing demand for fast dissolving dosage forms.

Tablets segment is registered the highest growth rate owing to the as tablets are the most used dosage form in the pharmaceutical industry and superdisintegrants are critical ingredients in tablet formulations.

Gastrointestinal diseases are projected to experience significant growth rate due to the growing incidence of GI disorders and increased focus on patient-centric drug delivery.

North America is expected to have the largest revenue share owing to the strong increasing incidence of chronic diseases and technological advancements.

APAC is projected to witness significant growth rate in the coming years due to the growing pharmaceutical industry in developing countries like China and India.

The global players include BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.

Polaris Market Research has segmented the superdisintegrants market report based on product, formulation, therapeutic area, and region:

Superdisintegrants, Product Outlook (Revenue - USD Million, 2019 - 2032)

Modified Starch

Modified Cellulose

Crospovidone

Ion Exchange Resin

Superdisintegrants, Formulation Outlook (Revenue - USD Million, 2019 - 2032)

Tablets

Capsules

Superdisintegrants, Therapeutic area Outlook (Revenue - USD Million, 2019 - 2032)

Gastrointestinal Diseases

Neurological Diseases

Oncology

Infectious Diseases

Cardiovascular Diseases

Hematological Diseases

Inflammatory Diseases

Superdisintegrants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa